Surprisingly, caspase-3 activity was not significantly increased by chlamydial infection at 48 hpi in the apaf-1−/− and control MEFs, compared to STS treatment (Fig. 5b). The gene discussed is CASP3; the disease is chlamydia trachomatis infectious disease.